TerraPower Isotopes to build $450M nuclear medicine facility in Philadelphia
USD450M
Deal Value
TerraPower Isotopes, a nuclear medicine company backed by Bill Gates, announced plans to build a $450 million manufacturing facility in South Philadelphia's Bellwether District. The 250,000-square-foot plant will produce rare radioactive isotopes (actinium-225) used for targeted alpha therapy in cancer treatment. The state is investing $10 million in the project, which is expected to create 225 full-time jobs over three years. Philadelphia was selected over 350 other potential sites due to its proximity to life science industries.
Get daily nuclear deal alerts — free, no spam.
Counterparts (3)
Investor
Developer
landlord
Register free to access full counterpart details, deal analysis, and timeline.
Register free →Timeline
Announced
Mar 17, 2026
Signed
Closed
Get the full picture — timeline, source intelligence, and counterpart analysis.
Register free →
Global Infrastructure Sherpa